EMCURE
Emcure Pharmaceuticals Limited
Pharmaceuticals
Share price
₹1,863
Market cap
₹35,392 Cr
1Y return
▲ 27%
A global pharmaceutical manufacturer established in 1981, Emcure Pharmaceuticals produces and markets a comprehensive range of drug formulations across multiple therapeutic areas for domestic and international markets. The company operates manufacturing facilities that serve patients globally, focusing on both generic and specialty pharmaceutical products. Emcure's diversified operations and geographic presence establish it as a significant player in the pharmaceutical industry.
Latest move
Morgan StanleyNew position
Morgan Stanley bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal. This transaction occurred on June 25, 2026.
Sign in to read more
Whales made 10 more moves in Emcure Pharmaceuticals Limited
Sign in to see who is buying and selling.
Sign in to find out